世界の凝固第XI因子市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Coagulation Factor XI Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5665
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、凝固第XI因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）、用途別市場規模（血栓症、出血＆凝固障害、急性虚血性脳卒中、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・凝固第XI因子の市場動向
・企業の競争状況、市場シェア
・凝固第XI因子の種類別市場規模と予測2016-2027（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）
・凝固第XI因子の用途別市場規模と予測2016-2027（血栓症、出血＆凝固障害、急性虚血性脳卒中、その他）
・凝固第XI因子の北米市場規模2016-2027（アメリカ、カナダ）
・凝固第XI因子の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・凝固第XI因子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・凝固第XI因子の中南米市場規模2016-2027（メキシコ、ブラジル）
・凝固第XI因子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer AG、Bristol-Myers Squibb Company、Cambryn Biologics LLC、eXithera Pharmaceuticals, Inc、Ionis Pharmaceuticals, Inc.、LegoChem Biosciences, Inc）
・結論

Market Analysis and Insights: Global Coagulation Factor XI Market
The global Coagulation Factor XI market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Coagulation Factor XI market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Coagulation Factor XI market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Coagulation Factor XI market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Coagulation Factor XI market.

Global Coagulation Factor XI Scope and Market Size
Coagulation Factor XI market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor XI market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others

Segment by Application
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coagulation Factor XI Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MR-1007
1.2.3 IONIS-FXIRx
1.2.4 EP-7041
1.2.5 AB-022
1.2.6 BMS-262084
1.2.7 Others
1.3 Market by Application
1.3.1 Global Coagulation Factor XI Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Thrombosis
1.3.3 Bleeding and Clotting Disorders
1.3.4 Acute Ischemic Stroke
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Coagulation Factor XI Market Perspective (2016-2027)
2.2 Coagulation Factor XI Growth Trends by Regions
2.2.1 Coagulation Factor XI Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Coagulation Factor XI Historic Market Share by Regions (2016-2021)
2.2.3 Coagulation Factor XI Forecasted Market Size by Regions (2022-2027)
2.3 Coagulation Factor XI Industry Dynamic
2.3.1 Coagulation Factor XI Market Trends
2.3.2 Coagulation Factor XI Market Drivers
2.3.3 Coagulation Factor XI Market Challenges
2.3.4 Coagulation Factor XI Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Coagulation Factor XI Players by Revenue
3.1.1 Global Top Coagulation Factor XI Players by Revenue (2016-2021)
3.1.2 Global Coagulation Factor XI Revenue Market Share by Players (2016-2021)
3.2 Global Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Coagulation Factor XI Revenue
3.4 Global Coagulation Factor XI Market Concentration Ratio
3.4.1 Global Coagulation Factor XI Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coagulation Factor XI Revenue in 2020
3.5 Coagulation Factor XI Key Players Head office and Area Served
3.6 Key Players Coagulation Factor XI Product Solution and Service
3.7 Date of Enter into Coagulation Factor XI Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Coagulation Factor XI Breakdown Data by Type
4.1 Global Coagulation Factor XI Historic Market Size by Type (2016-2021)
4.2 Global Coagulation Factor XI Forecasted Market Size by Type (2022-2027)

5 Coagulation Factor XI Breakdown Data by Application
5.1 Global Coagulation Factor XI Historic Market Size by Application (2016-2021)
5.2 Global Coagulation Factor XI Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Coagulation Factor XI Market Size (2016-2027)
6.2 North America Coagulation Factor XI Market Size by Type
6.2.1 North America Coagulation Factor XI Market Size by Type (2016-2021)
6.2.2 North America Coagulation Factor XI Market Size by Type (2022-2027)
6.2.3 North America Coagulation Factor XI Market Size by Type (2016-2027)
6.3 North America Coagulation Factor XI Market Size by Application
6.3.1 North America Coagulation Factor XI Market Size by Application (2016-2021)
6.3.2 North America Coagulation Factor XI Market Size by Application (2022-2027)
6.3.3 North America Coagulation Factor XI Market Size by Application (2016-2027)
6.4 North America Coagulation Factor XI Market Size by Country
6.4.1 North America Coagulation Factor XI Market Size by Country (2016-2021)
6.4.2 North America Coagulation Factor XI Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Coagulation Factor XI Market Size (2016-2027)
7.2 Europe Coagulation Factor XI Market Size by Type
7.2.1 Europe Coagulation Factor XI Market Size by Type (2016-2021)
7.2.2 Europe Coagulation Factor XI Market Size by Type (2022-2027)
7.2.3 Europe Coagulation Factor XI Market Size by Type (2016-2027)
7.3 Europe Coagulation Factor XI Market Size by Application
7.3.1 Europe Coagulation Factor XI Market Size by Application (2016-2021)
7.3.2 Europe Coagulation Factor XI Market Size by Application (2022-2027)
7.3.3 Europe Coagulation Factor XI Market Size by Application (2016-2027)
7.4 Europe Coagulation Factor XI Market Size by Country
7.4.1 Europe Coagulation Factor XI Market Size by Country (2016-2021)
7.4.2 Europe Coagulation Factor XI Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Coagulation Factor XI Market Size (2016-2027)
8.2 Asia-Pacific Coagulation Factor XI Market Size by Type
8.2.1 Asia-Pacific Coagulation Factor XI Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Coagulation Factor XI Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Coagulation Factor XI Market Size by Type (2016-2027)
8.3 Asia-Pacific Coagulation Factor XI Market Size by Application
8.3.1 Asia-Pacific Coagulation Factor XI Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Coagulation Factor XI Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Coagulation Factor XI Market Size by Application (2016-2027)
8.4 Asia-Pacific Coagulation Factor XI Market Size by Region
8.4.1 Asia-Pacific Coagulation Factor XI Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Coagulation Factor XI Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Coagulation Factor XI Market Size (2016-2027)
9.2 Latin America Coagulation Factor XI Market Size by Type
9.2.1 Latin America Coagulation Factor XI Market Size by Type (2016-2021)
9.2.2 Latin America Coagulation Factor XI Market Size by Type (2022-2027)
9.2.3 Latin America Coagulation Factor XI Market Size by Type (2016-2027)
9.3 Latin America Coagulation Factor XI Market Size by Application
9.3.1 Latin America Coagulation Factor XI Market Size by Application (2016-2021)
9.3.2 Latin America Coagulation Factor XI Market Size by Application (2022-2027)
9.3.3 Latin America Coagulation Factor XI Market Size by Application (2016-2027)
9.4 Latin America Coagulation Factor XI Market Size by Country
9.4.1 Latin America Coagulation Factor XI Market Size by Country (2016-2021)
9.4.2 Latin America Coagulation Factor XI Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Coagulation Factor XI Market Size (2016-2027)
10.2 Middle East & Africa Coagulation Factor XI Market Size by Type
10.2.1 Middle East & Africa Coagulation Factor XI Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Coagulation Factor XI Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Coagulation Factor XI Market Size by Type (2016-2027)
10.3 Middle East & Africa Coagulation Factor XI Market Size by Application
10.3.1 Middle East & Africa Coagulation Factor XI Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Coagulation Factor XI Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Coagulation Factor XI Market Size by Application (2016-2027)
10.4 Middle East & Africa Coagulation Factor XI Market Size by Country
10.4.1 Middle East & Africa Coagulation Factor XI Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Coagulation Factor XI Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Coagulation Factor XI Introduction
11.1.4 Bayer AG Revenue in Coagulation Factor XI Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Coagulation Factor XI Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Cambryn Biologics LLC
11.3.1 Cambryn Biologics LLC Company Details
11.3.2 Cambryn Biologics LLC Business Overview
11.3.3 Cambryn Biologics LLC Coagulation Factor XI Introduction
11.3.4 Cambryn Biologics LLC Revenue in Coagulation Factor XI Business (2016-2021)
11.3.5 Cambryn Biologics LLC Recent Development
11.4 eXithera Pharmaceuticals, Inc
11.4.1 eXithera Pharmaceuticals, Inc Company Details
11.4.2 eXithera Pharmaceuticals, Inc Business Overview
11.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Introduction
11.4.4 eXithera Pharmaceuticals, Inc Revenue in Coagulation Factor XI Business (2016-2021)
11.4.5 eXithera Pharmaceuticals, Inc Recent Development
11.5 Ionis Pharmaceuticals, Inc.
11.5.1 Ionis Pharmaceuticals, Inc. Company Details
11.5.2 Ionis Pharmaceuticals, Inc. Business Overview
11.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Introduction
11.5.4 Ionis Pharmaceuticals, Inc. Revenue in Coagulation Factor XI Business (2016-2021)
11.5.5 Ionis Pharmaceuticals, Inc. Recent Development
11.6 LegoChem Biosciences, Inc
11.6.1 LegoChem Biosciences, Inc Company Details
11.6.2 LegoChem Biosciences, Inc Business Overview
11.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Introduction
11.6.4 LegoChem Biosciences, Inc Revenue in Coagulation Factor XI Business (2016-2021)
11.6.5 LegoChem Biosciences, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Coagulation Factor XI Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MR-1007
Table 3. Key Players of IONIS-FXIRx
Table 4. Key Players of EP-7041
Table 5. Key Players of AB-022
Table 6. Key Players of BMS-262084
Table 7. Key Players of Others
Table 8. Global Coagulation Factor XI Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Coagulation Factor XI Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Coagulation Factor XI Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Coagulation Factor XI Market Share by Regions (2016-2021)
Table 12. Global Coagulation Factor XI Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Coagulation Factor XI Market Share by Regions (2022-2027)
Table 14. Coagulation Factor XI Market Trends
Table 15. Coagulation Factor XI Market Drivers
Table 16. Coagulation Factor XI Market Challenges
Table 17. Coagulation Factor XI Market Restraints
Table 18. Global Coagulation Factor XI Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Coagulation Factor XI Market Share by Players (2016-2021)
Table 20. Global Top Coagulation Factor XI Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor XI as of 2020)
Table 21. Ranking of Global Top Coagulation Factor XI Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Coagulation Factor XI Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Coagulation Factor XI Product Solution and Service
Table 25. Date of Enter into Coagulation Factor XI Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Coagulation Factor XI Revenue Market Share by Type (2016-2021)
Table 29. Global Coagulation Factor XI Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Coagulation Factor XI Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Coagulation Factor XI Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Coagulation Factor XI Revenue Market Share by Application (2016-2021)
Table 33. Global Coagulation Factor XI Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Coagulation Factor XI Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Coagulation Factor XI Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Coagulation Factor XI Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Coagulation Factor XI Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Coagulation Factor XI Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Coagulation Factor XI Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Coagulation Factor XI Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Coagulation Factor XI Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Coagulation Factor XI Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Coagulation Factor XI Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Coagulation Factor XI Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Coagulation Factor XI Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Coagulation Factor XI Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Coagulation Factor XI Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Coagulation Factor XI Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Coagulation Factor XI Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Coagulation Factor XI Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Coagulation Factor XI Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Coagulation Factor XI Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Coagulation Factor XI Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Coagulation Factor XI Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Coagulation Factor XI Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Coagulation Factor XI Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Coagulation Factor XI Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Coagulation Factor XI Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Coagulation Factor XI Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Coagulation Factor XI Market Size by Country (2022-2027) & (US$ Million)
Table 65. Bayer AG Company Details
Table 66. Bayer AG Business Overview
Table 67. Bayer AG Coagulation Factor XI Product
Table 68. Bayer AG Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 69. Bayer AG Recent Development
Table 70. Bristol-Myers Squibb Company Company Details
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Coagulation Factor XI Product
Table 73. Bristol-Myers Squibb Company Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Cambryn Biologics LLC Company Details
Table 76. Cambryn Biologics LLC Business Overview
Table 77. Cambryn Biologics LLC Coagulation Factor XI Product
Table 78. Cambryn Biologics LLC Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 79. Cambryn Biologics LLC Recent Development
Table 80. eXithera Pharmaceuticals, Inc Company Details
Table 81. eXithera Pharmaceuticals, Inc Business Overview
Table 82. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product
Table 83. eXithera Pharmaceuticals, Inc Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 84. eXithera Pharmaceuticals, Inc Recent Development
Table 85. Ionis Pharmaceuticals, Inc. Company Details
Table 86. Ionis Pharmaceuticals, Inc. Business Overview
Table 87. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product
Table 88. Ionis Pharmaceuticals, Inc. Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 89. Ionis Pharmaceuticals, Inc. Recent Development
Table 90. LegoChem Biosciences, Inc Company Details
Table 91. LegoChem Biosciences, Inc Business Overview
Table 92. LegoChem Biosciences, Inc Coagulation Factor XI Product
Table 93. LegoChem Biosciences, Inc Revenue in Coagulation Factor XI Business (2016-2021) & (US$ Million)
Table 94. LegoChem Biosciences, Inc Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coagulation Factor XI Market Share by Type: 2020 VS 2027
Figure 2. MR-1007 Features
Figure 3. IONIS-FXIRx Features
Figure 4. EP-7041 Features
Figure 5. AB-022 Features
Figure 6. BMS-262084 Features
Figure 7. Others Features
Figure 8. Global Coagulation Factor XI Market Share by Application: 2020 VS 2027
Figure 9. Thrombosis Case Studies
Figure 10. Bleeding and Clotting Disorders Case Studies
Figure 11. Acute Ischemic Stroke Case Studies
Figure 12. Others Case Studies
Figure 13. Coagulation Factor XI Report Years Considered
Figure 14. Global Coagulation Factor XI Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Coagulation Factor XI Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Coagulation Factor XI Market Share by Regions: 2020 VS 2027
Figure 17. Global Coagulation Factor XI Market Share by Regions (2022-2027)
Figure 18. Global Coagulation Factor XI Market Share by Players in 2020
Figure 19. Global Top Coagulation Factor XI Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor XI as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Coagulation Factor XI Revenue in 2020
Figure 21. Global Coagulation Factor XI Revenue Market Share by Type (2016-2021)
Figure 22. Global Coagulation Factor XI Revenue Market Share by Type (2022-2027)
Figure 23. North America Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Coagulation Factor XI Market Share by Type (2016-2027)
Figure 25. North America Coagulation Factor XI Market Share by Application (2016-2027)
Figure 26. North America Coagulation Factor XI Market Share by Country (2016-2027)
Figure 27. United States Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Coagulation Factor XI Market Share by Type (2016-2027)
Figure 31. Europe Coagulation Factor XI Market Share by Application (2016-2027)
Figure 32. Europe Coagulation Factor XI Market Share by Country (2016-2027)
Figure 33. Germany Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Coagulation Factor XI Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Coagulation Factor XI Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Coagulation Factor XI Market Share by Region (2016-2027)
Figure 43. China Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Coagulation Factor XI Market Share by Type (2016-2027)
Figure 51. Latin America Coagulation Factor XI Market Share by Application (2016-2027)
Figure 52. Latin America Coagulation Factor XI Market Share by Country (2016-2027)
Figure 53. Mexico Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Coagulation Factor XI Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Coagulation Factor XI Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Coagulation Factor XI Market Share by Country (2016-2027)
Figure 59. Turkey Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Coagulation Factor XI Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer AG Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 64. Cambryn Biologics LLC Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 65. eXithera Pharmaceuticals, Inc Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 66. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 67. LegoChem Biosciences, Inc Revenue Growth Rate in Coagulation Factor XI Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027
QFJ1-6050 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XOMA-089、トラベダーセン、ISTH-0047、その他）、用途別市場規模（多形性膠芽腫、開放隅角緑内障、肝線...

世界の特殊凝固検査市場規模・現状・予測（2021年-2027年）

Global Special Coagulation Test Market Size, Status and Forecast 2021-2027
QFJ1-4886 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、特殊凝固検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロトロンビン時間試験、活性化凝固時間試験、ACTヘパリン・プロタミン用量反応試験、その他）、用途別市場規模（病院、クリニック、診断研究所）...

世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5898 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年）

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6054 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腫瘍壊死因子（TNF）阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Humira、Enbrel、Remicade、Simponi/Simponi Aria、Cimzia、バイオシミラー）、用途...

世界の顆粒球コロニー刺激因子（G-CSF）薬剤市場規模・現状・予測（2021年-2027年）

Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5760 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、顆粒球コロニー刺激因子（G-CSF）薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（フィルグラスチム、ペフィグラスチム、リペフィグラスチム）、用途別市場規模（腫瘍学、造血系疾患、その他）、主要地域...

世界のプレリキサフォル市場規模・現状・予測（2021年-2027年）

Global Plerixafor Market Size, Status and Forecast 2021-2027
QFJ1-5955 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、プレリキサフォルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（24MG / 1.2ML、タイプII）、用途別市場規模（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別市場規模...

世界のバレニクリン市場規模・現状・予測（2021年-2027年）

Global Varenicline Market Size, Status and Forecast 2021-2027
QFJ1-6060 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、バレニクリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（0.5mg錠、1mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027
QFJ1-6028 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（...

世界の特殊凝固検査市場規模・現状・予測（2021年-2027年） The special coagulation test measures the capability of the blood to form a clot in case of physical injury leading to blood loss. The special coagulation laboratory tests are useful in elucidating the cause of excessive bleeding. Moreover, the tests do not provide information concerning the occurre…
世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…
世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年） Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …